OPDIVO 10 mg/mL concentrate for solution for infusion., BDC-1001, OPDIVO 10 mg/mL concentrate for solution for infusion., OPDIVO 10 mg/mL concentrate for solution for infusion.
BBI-20201001
Phase 2 small_molecule active
Quick answer
OPDIVO 10 mg/mL concentrate for solution for infusion., BDC-1001, OPDIVO 10 mg/mL concentrate for solution for infusion., OPDIVO 10 mg/mL concentrate for solution for infusion. for Advanced HER2-Expressing Solid Tumors. is a Phase 2 program (small_molecule) at Bolt Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bolt Biotherapeutics
- Indication
- Advanced HER2-Expressing Solid Tumors.
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active